See also this year's filing and all EDGAR filings for this company.
PDF Report 0001365216_2013_Sucampo_Pharmaceuticals_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001365216, Sucampo Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 92,914,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 7,415,000 |
| 2 | PropertyPlantAndEquipmentNet | 1,540,000 |
| 3 | remainder_Assets | 25,927,000 |
| 4 | LiabilitiesCurrent | 40,071,000 |
| 5 | LiabilitiesNoncurrent | 1,253,000 |
| 6 | remainder_Liabilities | 43,442,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 30,157,000 |
| 9 | ResearchAndDevelopmentExpense | 21,292,000 |
| 10 | remainder_Expenses | 24,637,000 |
| 11 | remainder_Revenues | 81,487,000 |
| 12 | remainder_NetIncome | -565,000 |
| 13 | remainder_ComprehensiveNetIncome | -1,688,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 127,796,000 |
| 1 | Liabilities | 84,766,000 |
| 2 | Expenses | 76,086,000 |
| 3 | Revenues | 81,487,000 |
| 4 | StockholdersEquity | 43,030,000 |
| 5 | NetIncome | 4,836,000 |
| 6 | ComprehensiveNetIncome | 3,992,000 |
| 7 | BaseVar | 186,194,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.920 |
| 9 | EconomicCapitalRatio | 2.24 |
Edgar->Model Mapping
Feature Distribution
Change over Time
